nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—hepatitis B	0.627	1	CbGaD
Sulfamethoxazole—Nephrotoxicity—Adefovir Dipivoxil—hepatitis B	0.0159	0.0613	CcSEcCtD
Sulfamethoxazole—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.0088	0.0339	CcSEcCtD
Sulfamethoxazole—NAT1—Phase II conjugation—GGT2—hepatitis B	0.00699	0.0833	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Nicotine Metabolism—CYP2A6—hepatitis B	0.00524	0.0625	CbGpPWpGaD
Sulfamethoxazole—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00496	0.0191	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Telbivudine—hepatitis B	0.00481	0.0185	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—GGT2—hepatitis B	0.00409	0.0487	CbGpPWpGaD
Sulfamethoxazole—NAT1—blood—hepatitis B	0.00408	0.163	CbGeAlD
Sulfamethoxazole—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00385	0.0149	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Lamivudine—hepatitis B	0.00355	0.0137	CcSEcCtD
Sulfamethoxazole—NAT2—liver—hepatitis B	0.00351	0.14	CbGeAlD
Sulfamethoxazole—NAT1—Phase II conjugation—GGT1—hepatitis B	0.0033	0.0394	CbGpPWpGaD
Sulfamethoxazole—Renal impairment—Telbivudine—hepatitis B	0.00325	0.0125	CcSEcCtD
Sulfamethoxazole—NAT1—liver—hepatitis B	0.00319	0.128	CbGeAlD
Sulfamethoxazole—Pancreatitis—Entecavir—hepatitis B	0.00319	0.0123	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00311	0.012	CcSEcCtD
Sulfamethoxazole—Neutropenia—Entecavir—hepatitis B	0.00304	0.0117	CcSEcCtD
Sulfamethoxazole—NAT2—Phase II conjugation—GGT2—hepatitis B	0.0029	0.0346	CbGpPWpGaD
Sulfamethoxazole—Blood disorder—Lamivudine—hepatitis B	0.00287	0.0111	CcSEcCtD
Sulfamethoxazole—Renal failure—Entecavir—hepatitis B	0.00285	0.011	CcSEcCtD
Sulfamethoxazole—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00278	0.0107	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Entecavir—hepatitis B	0.00274	0.0106	CcSEcCtD
Sulfamethoxazole—Rhabdomyolysis—Lamivudine—hepatitis B	0.00271	0.0104	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00267	0.0103	CcSEcCtD
Sulfamethoxazole—Hepatitis—Entecavir—hepatitis B	0.0026	0.01	CcSEcCtD
Sulfamethoxazole—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00254	0.00978	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00251	0.00966	CcSEcCtD
Sulfamethoxazole—Neutropenia—Telbivudine—hepatitis B	0.0025	0.00962	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00249	0.00961	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00249	0.00959	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—CYP2A6—hepatitis B	0.00248	0.0295	CbGpPWpGaD
Sulfamethoxazole—ALB—Scavenging of heme from plasma—HP—hepatitis B	0.00235	0.028	CbGpPWpGaD
Sulfamethoxazole—Immune system disorder—Entecavir—hepatitis B	0.00235	0.00906	CcSEcCtD
Sulfamethoxazole—Renal failure—Telbivudine—hepatitis B	0.00234	0.00902	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Telbivudine—hepatitis B	0.00233	0.00899	CcSEcCtD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.00233	0.0277	CbGpPWpGaD
Sulfamethoxazole—Mental disorder—Entecavir—hepatitis B	0.00228	0.00878	CcSEcCtD
Sulfamethoxazole—Malnutrition—Entecavir—hepatitis B	0.00226	0.00873	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Lamivudine—hepatitis B	0.00225	0.00868	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Telbivudine—hepatitis B	0.00225	0.00868	CcSEcCtD
Sulfamethoxazole—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00221	0.00852	CcSEcCtD
Sulfamethoxazole—CYP2C8—blood plasma—hepatitis B	0.00215	0.0857	CbGeAlD
Sulfamethoxazole—Hepatitis—Telbivudine—hepatitis B	0.00214	0.00824	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Telbivudine—hepatitis B	0.0021	0.00809	CcSEcCtD
Sulfamethoxazole—Leukopenia—Entecavir—hepatitis B	0.00203	0.00781	CcSEcCtD
Sulfamethoxazole—Polyuria—Lamivudine—hepatitis B	0.00198	0.00764	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—GGT1—hepatitis B	0.00193	0.023	CbGpPWpGaD
Sulfamethoxazole—Cough—Adefovir Dipivoxil—hepatitis B	0.00193	0.00743	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Telbivudine—hepatitis B	0.00193	0.00742	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00191	0.00738	CcSEcCtD
Sulfamethoxazole—CYP2C9—blood plasma—hepatitis B	0.00191	0.0761	CbGeAlD
Sulfamethoxazole—UGT1A9—liver—hepatitis B	0.0019	0.0757	CbGeAlD
Sulfamethoxazole—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00188	0.00725	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00187	0.0072	CcSEcCtD
Sulfamethoxazole—Malnutrition—Telbivudine—hepatitis B	0.00186	0.00717	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Entecavir—hepatitis B	0.00185	0.00712	CcSEcCtD
Sulfamethoxazole—Renal impairment—Lamivudine—hepatitis B	0.00183	0.00705	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Entecavir—hepatitis B	0.00181	0.00699	CcSEcCtD
Sulfamethoxazole—Skin disorder—Entecavir—hepatitis B	0.00179	0.00692	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Lamivudine—hepatitis B	0.00178	0.00688	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00177	0.00682	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00177	0.00681	CcSEcCtD
Sulfamethoxazole—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00175	0.00675	CcSEcCtD
Sulfamethoxazole—NAT2—Metapathway biotransformation—AKR1B1—hepatitis B	0.00175	0.0208	CbGpPWpGaD
Sulfamethoxazole—PTGS1—blood plasma—hepatitis B	0.00174	0.0695	CbGeAlD
Sulfamethoxazole—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00172	0.00663	CcSEcCtD
Sulfamethoxazole—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.0017	0.0203	CbGpPWpGaD
Sulfamethoxazole—NAT2—Biological oxidations—GGT2—hepatitis B	0.0017	0.0202	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Entecavir—hepatitis B	0.00167	0.00644	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00164	0.00633	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Entecavir—hepatitis B	0.00163	0.00627	CcSEcCtD
Sulfamethoxazole—Cough—Telbivudine—hepatitis B	0.00162	0.00626	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Entecavir—hepatitis B	0.0016	0.00615	CcSEcCtD
Sulfamethoxazole—Fatigue—Entecavir—hepatitis B	0.00159	0.00614	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00159	0.00612	CcSEcCtD
Sulfamethoxazole—Myalgia—Telbivudine—hepatitis B	0.00158	0.0061	CcSEcCtD
Sulfamethoxazole—Arthralgia—Telbivudine—hepatitis B	0.00158	0.0061	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00157	0.00606	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00157	0.00604	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00156	0.006	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Entecavir—hepatitis B	0.00151	0.00583	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Telbivudine—hepatitis B	0.00149	0.00574	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Telbivudine—hepatitis B	0.00149	0.00573	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Lamivudine—hepatitis B	0.00147	0.00569	CcSEcCtD
Sulfamethoxazole—Skin disorder—Telbivudine—hepatitis B	0.00147	0.00568	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00147	0.00568	CcSEcCtD
Sulfamethoxazole—Sulfaphenazole—CYP2A6—hepatitis B	0.00147	0.32	CrCbGaD
Sulfamethoxazole—Abdominal pain—Entecavir—hepatitis B	0.00146	0.00563	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Entecavir—hepatitis B	0.00146	0.00563	CcSEcCtD
Sulfamethoxazole—CYP3A4—blood plasma—hepatitis B	0.00145	0.0581	CbGeAlD
Sulfamethoxazole—Pancytopenia—Lamivudine—hepatitis B	0.00143	0.00551	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00143	0.00549	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00143	0.00549	CcSEcCtD
Sulfamethoxazole—Neutropenia—Lamivudine—hepatitis B	0.00141	0.00542	CcSEcCtD
Sulfamethoxazole—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00138	0.0165	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00138	0.00533	CcSEcCtD
Sulfamethoxazole—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00137	0.0164	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Telbivudine—hepatitis B	0.00137	0.00529	CcSEcCtD
Sulfamethoxazole—NAT2—Phase II conjugation—GGT1—hepatitis B	0.00137	0.0164	CbGpPWpGaD
Sulfamethoxazole—Depression—Lamivudine—hepatitis B	0.00134	0.00516	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Telbivudine—hepatitis B	0.00134	0.00515	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00133	0.00513	CcSEcCtD
Sulfamethoxazole—Asthenia—Entecavir—hepatitis B	0.00133	0.00511	CcSEcCtD
Sulfamethoxazole—Renal failure—Lamivudine—hepatitis B	0.00132	0.00508	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Lamivudine—hepatitis B	0.00131	0.00507	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00131	0.00505	CcSEcCtD
Sulfamethoxazole—Fatigue—Telbivudine—hepatitis B	0.00131	0.00505	CcSEcCtD
Sulfamethoxazole—Stomatitis—Lamivudine—hepatitis B	0.00131	0.00504	CcSEcCtD
Sulfamethoxazole—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00129	0.00499	CcSEcCtD
Sulfamethoxazole—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00128	0.00492	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Lamivudine—hepatitis B	0.00127	0.00489	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Entecavir—hepatitis B	0.00126	0.00487	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Lamivudine—hepatitis B	0.00125	0.00483	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Telbivudine—hepatitis B	0.00124	0.00479	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00123	0.00476	CcSEcCtD
Sulfamethoxazole—Dizziness—Entecavir—hepatitis B	0.00122	0.00471	CcSEcCtD
Sulfamethoxazole—Hepatitis—Lamivudine—hepatitis B	0.0012	0.00464	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Telbivudine—hepatitis B	0.0012	0.00463	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Telbivudine—hepatitis B	0.0012	0.00463	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Lamivudine—hepatitis B	0.00118	0.00456	CcSEcCtD
Sulfamethoxazole—Vomiting—Entecavir—hepatitis B	0.00117	0.00453	CcSEcCtD
Sulfamethoxazole—Rash—Entecavir—hepatitis B	0.00117	0.00449	CcSEcCtD
Sulfamethoxazole—Dermatitis—Entecavir—hepatitis B	0.00116	0.00449	CcSEcCtD
Sulfamethoxazole—Headache—Entecavir—hepatitis B	0.00116	0.00446	CcSEcCtD
Sulfamethoxazole—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00115	0.00442	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Lamivudine—hepatitis B	0.00114	0.00439	CcSEcCtD
Sulfamethoxazole—Sulfamethazine—ALB—hepatitis B	0.00114	0.249	CrCbGaD
Sulfamethoxazole—Rash—Adefovir Dipivoxil—hepatitis B	0.00114	0.00438	CcSEcCtD
Sulfamethoxazole—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00114	0.00438	CcSEcCtD
Sulfamethoxazole—Headache—Adefovir Dipivoxil—hepatitis B	0.00113	0.00435	CcSEcCtD
Sulfamethoxazole—Sulfamerazine—ALB—hepatitis B	0.00111	0.243	CrCbGaD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.0011	0.0131	CbGpPWpGaD
Sulfamethoxazole—Nausea—Entecavir—hepatitis B	0.0011	0.00423	CcSEcCtD
Sulfamethoxazole—Asthenia—Telbivudine—hepatitis B	0.00109	0.0042	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Lamivudine—hepatitis B	0.00109	0.00419	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Lamivudine—hepatitis B	0.00109	0.00418	CcSEcCtD
Sulfamethoxazole—Chills—Lamivudine—hepatitis B	0.00108	0.00417	CcSEcCtD
Sulfamethoxazole—Pruritus—Telbivudine—hepatitis B	0.00107	0.00414	CcSEcCtD
Sulfamethoxazole—Nausea—Adefovir Dipivoxil—hepatitis B	0.00107	0.00413	CcSEcCtD
Sulfamethoxazole—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.00105	0.0126	CbGpPWpGaD
Sulfamethoxazole—Malnutrition—Lamivudine—hepatitis B	0.00105	0.00404	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Telbivudine—hepatitis B	0.00104	0.004	CcSEcCtD
Sulfamethoxazole—Tension—Lamivudine—hepatitis B	0.00103	0.00397	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—CYP2A6—hepatitis B	0.00103	0.0123	CbGpPWpGaD
Sulfamethoxazole—Nervousness—Lamivudine—hepatitis B	0.00102	0.00392	CcSEcCtD
Sulfamethoxazole—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00101	0.0121	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Phase II conjugation—GGT2—hepatitis B	0.00101	0.012	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Telbivudine—hepatitis B	0.001	0.00387	CcSEcCtD
Sulfamethoxazole—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000973	0.0116	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Telbivudine—hepatitis B	0.000965	0.00372	CcSEcCtD
Sulfamethoxazole—Angioedema—Lamivudine—hepatitis B	0.000958	0.00369	CcSEcCtD
Sulfamethoxazole—Rash—Telbivudine—hepatitis B	0.000957	0.00369	CcSEcCtD
Sulfamethoxazole—Dermatitis—Telbivudine—hepatitis B	0.000956	0.00369	CcSEcCtD
Sulfamethoxazole—Headache—Telbivudine—hepatitis B	0.000951	0.00367	CcSEcCtD
Sulfamethoxazole—Vertigo—Lamivudine—hepatitis B	0.000942	0.00363	CcSEcCtD
Sulfamethoxazole—Leukopenia—Lamivudine—hepatitis B	0.000938	0.00362	CcSEcCtD
Sulfamethoxazole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—hepatitis B	0.000937	0.0112	CbGpPWpGaD
Sulfamethoxazole—Cough—Lamivudine—hepatitis B	0.000915	0.00353	CcSEcCtD
Sulfamethoxazole—Convulsion—Lamivudine—hepatitis B	0.000908	0.0035	CcSEcCtD
Sulfamethoxazole—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000904	0.0108	CbGpPWpGaD
Sulfamethoxazole—Nausea—Telbivudine—hepatitis B	0.000902	0.00348	CcSEcCtD
Sulfamethoxazole—Arthralgia—Lamivudine—hepatitis B	0.000892	0.00344	CcSEcCtD
Sulfamethoxazole—Myalgia—Lamivudine—hepatitis B	0.000892	0.00344	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000886	0.00342	CcSEcCtD
Sulfamethoxazole—ALB—liver—hepatitis B	0.000875	0.0349	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—hepatitis B	0.000863	0.188	CrCbGaD
Sulfamethoxazole—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000858	0.0102	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Lamivudine—hepatitis B	0.000855	0.0033	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Lamivudine—hepatitis B	0.000839	0.00323	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Lamivudine—hepatitis B	0.000838	0.00323	CcSEcCtD
Sulfamethoxazole—Skin disorder—Lamivudine—hepatitis B	0.000831	0.0032	CcSEcCtD
Sulfamethoxazole—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000825	0.00983	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.000823	0.00981	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Lamivudine—hepatitis B	0.000815	0.00314	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—GGT1—hepatitis B	0.000803	0.00957	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—blood—hepatitis B	0.000786	0.0314	CbGeAlD
Sulfamethoxazole—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000779	0.003	CcSEcCtD
Sulfamethoxazole—Insomnia—Lamivudine—hepatitis B	0.000774	0.00298	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Lamivudine—hepatitis B	0.000763	0.00294	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Lamivudine—hepatitis B	0.000753	0.0029	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Lamivudine—hepatitis B	0.000744	0.00287	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000739	0.00285	CcSEcCtD
Sulfamethoxazole—Fatigue—Lamivudine—hepatitis B	0.000738	0.00284	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—AKR1B1—hepatitis B	0.000729	0.00869	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Lamivudine—hepatitis B	0.0007	0.0027	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—GGT2—hepatitis B	0.000699	0.00833	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—blood—hepatitis B	0.000698	0.0279	CbGeAlD
Sulfamethoxazole—Urticaria—Lamivudine—hepatitis B	0.00068	0.00262	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Lamivudine—hepatitis B	0.000676	0.00261	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lamivudine—hepatitis B	0.000676	0.00261	CcSEcCtD
Sulfamethoxazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000676	0.00806	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GGT2—hepatitis B	0.000673	0.00802	CbGpPWpGaD
Sulfamethoxazole—PTGS1—blood—hepatitis B	0.000638	0.0255	CbGeAlD
Sulfamethoxazole—Hypersensitivity—Lamivudine—hepatitis B	0.00063	0.00243	CcSEcCtD
Sulfamethoxazole—CYP2C8—liver—hepatitis B	0.000615	0.0246	CbGeAlD
Sulfamethoxazole—Asthenia—Lamivudine—hepatitis B	0.000614	0.00237	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.000612	0.00729	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000608	0.00724	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Lamivudine—hepatitis B	0.000605	0.00233	CcSEcCtD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.000593	0.00707	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—GGT2—hepatitis B	0.000591	0.00704	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000589	0.00702	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Lamivudine—hepatitis B	0.000585	0.00226	CcSEcCtD
Sulfamethoxazole—Dizziness—Lamivudine—hepatitis B	0.000566	0.00218	CcSEcCtD
Sulfamethoxazole—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000566	0.00674	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000549	0.00654	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—liver—hepatitis B	0.000546	0.0218	CbGeAlD
Sulfamethoxazole—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000544	0.00648	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Lamivudine—hepatitis B	0.000544	0.0021	CcSEcCtD
Sulfamethoxazole—Rash—Lamivudine—hepatitis B	0.000539	0.00208	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lamivudine—hepatitis B	0.000539	0.00208	CcSEcCtD
Sulfamethoxazole—Headache—Lamivudine—hepatitis B	0.000536	0.00207	CcSEcCtD
Sulfamethoxazole—CYP3A4—blood—hepatitis B	0.000533	0.0213	CbGeAlD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—GGT2—hepatitis B	0.000529	0.0063	CbGpPWpGaD
Sulfamethoxazole—Nausea—Lamivudine—hepatitis B	0.000508	0.00196	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000481	0.00574	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Phase II conjugation—GGT1—hepatitis B	0.000478	0.00569	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00046	0.00548	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000438	0.00521	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000432	0.00515	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CYP2A6—hepatitis B	0.000424	0.00505	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000417	0.00497	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—liver—hepatitis B	0.000416	0.0166	CbGeAlD
Sulfamethoxazole—UGT1A9—NRF2 pathway—CYP2A6—hepatitis B	0.000408	0.00486	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000395	0.00471	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000389	0.00464	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.000389	0.00464	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000388	0.00463	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GOT2—hepatitis B	0.000383	0.00456	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP2A6—hepatitis B	0.000358	0.00426	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000356	0.00424	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000355	0.00423	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000351	0.00419	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000346	0.00412	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.000336	0.00401	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GGT1—hepatitis B	0.000331	0.00394	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GOT1—hepatitis B	0.000331	0.00394	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000322	0.00383	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.00032	0.00381	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—HSPA5—hepatitis B	0.00032	0.00381	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GGT1—hepatitis B	0.000318	0.0038	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000311	0.00371	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000305	0.00363	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKR1B1—hepatitis B	0.000303	0.00361	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.000292	0.00348	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GGT2—hepatitis B	0.00029	0.00346	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000289	0.00344	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—GGT1—hepatitis B	0.000279	0.00333	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000279	0.00332	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00027	0.00322	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00026	0.0031	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000253	0.00302	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000252	0.003	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.00025	0.00298	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000249	0.00297	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000248	0.00295	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000237	0.00282	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000235	0.0028	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000232	0.00276	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000228	0.00271	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HBE1—hepatitis B	0.000211	0.00252	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000207	0.00247	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—F2—hepatitis B	0.000202	0.0024	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000193	0.0023	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00019	0.00227	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000189	0.00225	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000188	0.00225	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000188	0.00224	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP2A6—hepatitis B	0.000176	0.0021	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ALB—hepatitis B	0.000176	0.0021	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000172	0.00205	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000167	0.00199	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—F2—hepatitis B	0.00016	0.00191	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GOT2—hepatitis B	0.000159	0.0019	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000157	0.00187	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	0.000156	0.00186	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000153	0.00183	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IFNG—hepatitis B	0.000153	0.00182	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000147	0.00175	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000142	0.00169	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GOT1—hepatitis B	0.000137	0.00164	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GGT1—hepatitis B	0.000137	0.00164	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—hepatitis B	0.000136	0.00162	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTEN—hepatitis B	0.000134	0.0016	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—NFKB1—hepatitis B	0.000127	0.00151	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000125	0.00148	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000124	0.00148	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000122	0.00146	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	0.000122	0.00145	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	0.000121	0.00145	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.00012	0.00143	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000107	0.00128	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—hepatitis B	0.000107	0.00128	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKR1B1—hepatitis B	0.000105	0.00126	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000101	0.00121	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000101	0.00121	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GGT2—hepatitis B	0.000101	0.0012	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000101	0.0012	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—hepatitis B	9.89e-05	0.00118	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	9.87e-05	0.00118	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	9.81e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—hepatitis B	9.08e-05	0.00108	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.74e-05	0.00104	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—hepatitis B	8.72e-05	0.00104	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	8.65e-05	0.00103	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKR1B1—hepatitis B	8.59e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GGT2—hepatitis B	8.23e-05	0.000981	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—hepatitis B	7.98e-05	0.000951	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GGT1—hepatitis B	7.9e-05	0.000941	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—hepatitis B	7.85e-05	0.000936	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	7.67e-05	0.000913	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HSPA5—hepatitis B	7.31e-05	0.000871	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ALB—hepatitis B	7.3e-05	0.00087	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNB1—hepatitis B	6.6e-05	0.000786	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA1—hepatitis B	6.43e-05	0.000767	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—hepatitis B	6.34e-05	0.000755	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP2A6—hepatitis B	6.12e-05	0.000729	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA2—hepatitis B	5.99e-05	0.000714	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.71e-05	0.00068	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.65e-05	0.000673	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.62e-05	0.000669	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—hepatitis B	5.57e-05	0.000664	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKR1B1—hepatitis B	5.55e-05	0.000661	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GOT2—hepatitis B	5.53e-05	0.00066	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKR1B1—hepatitis B	5.52e-05	0.000657	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GGT2—hepatitis B	5.32e-05	0.000634	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GGT2—hepatitis B	5.29e-05	0.00063	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	5.16e-05	0.000615	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2A6—hepatitis B	4.99e-05	0.000594	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GOT1—hepatitis B	4.78e-05	0.000569	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GGT1—hepatitis B	4.78e-05	0.000569	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.65e-05	0.000554	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.6e-05	0.000548	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1B1—hepatitis B	4.52e-05	0.000538	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GOT2—hepatitis B	4.51e-05	0.000538	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.35e-05	0.000519	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GGT2—hepatitis B	4.33e-05	0.000516	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	4.03e-05	0.00048	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—F2—hepatitis B	3.95e-05	0.000471	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS2—hepatitis B	3.9e-05	0.000465	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GOT1—hepatitis B	3.89e-05	0.000464	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GGT1—hepatitis B	3.89e-05	0.000464	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.55e-05	0.000423	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2A6—hepatitis B	3.22e-05	0.000384	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2A6—hepatitis B	3.2e-05	0.000382	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3e-05	0.000358	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.98e-05	0.000355	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GOT2—hepatitis B	2.91e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GOT2—hepatitis B	2.9e-05	0.000345	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GGT2—hepatitis B	2.85e-05	0.00034	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—hepatitis B	2.66e-05	0.000317	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.62e-05	0.000313	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—hepatitis B	2.54e-05	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GGT1—hepatitis B	2.52e-05	0.0003	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GOT1—hepatitis B	2.52e-05	0.0003	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GGT1—hepatitis B	2.5e-05	0.000298	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GOT1—hepatitis B	2.5e-05	0.000298	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.45e-05	0.000291	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GOT2—hepatitis B	2.37e-05	0.000283	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.29e-05	0.000273	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.28e-05	0.000272	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—hepatitis B	2.08e-05	0.000247	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—hepatitis B	2.07e-05	0.000247	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GOT1—hepatitis B	2.05e-05	0.000244	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GGT1—hepatitis B	2.05e-05	0.000244	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—hepatitis B	1.94e-05	0.000231	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.87e-05	0.000222	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.73e-05	0.000206	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—hepatitis B	1.71e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—hepatitis B	1.58e-05	0.000188	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GOT2—hepatitis B	1.56e-05	0.000186	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GOT1—hepatitis B	1.35e-05	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GGT1—hepatitis B	1.35e-05	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—hepatitis B	1.34e-05	0.000159	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—hepatitis B	1.09e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—hepatitis B	1.02e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—hepatitis B	1.02e-05	0.000121	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—hepatitis B	8.31e-06	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—hepatitis B	7.18e-06	8.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—hepatitis B	5.48e-06	6.53e-05	CbGpPWpGaD
